U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  5. FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health (PATH) Study to Inform FDA’s Regulatory Activities - 01/09/2025
  1. FDA Grand Rounds

Webcast | Virtual

Event Title
FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health (PATH) Study to Inform FDA’s Regulatory Activities
January 9, 2025

Date:
January 9, 2025
Time:
12:00 p.m. - 1:00 p.m. ET
Image
FDA Grand Rounds - The PATH from Data to Action

Speaker 

Yu-Ching Cheng, Ph.D.

Yu-Ching Cheng, Ph.D.
Supervisory Epidemiologist
Division of Research and Knowledge Integration
Office of Science
Center for Tobacco Products

About the Speaker

Dr. Yu-Ching Cheng is a Supervisory Epidemiologist of the Population Assessment of Tobacco and Health (PATH) Branch in the Division of Research and Knowledge Integration (DRKI), Office of Science (OS), Center for Tobacco Products (CTP) at the Food and Drug Administration (FDA). The PATH Branch supports the PATH Study, a large, national, longitudinal cohort study on tobacco use and health conducted in collaboration with the National Institute on Drug Abuse, National Institutes of Health. In her current role, she leads a team of epidemiologists, statisticians, and health scientists responsible for data analysis, research coordination and dissemination and day-to-day management of the PATH Study. Prior to joining FDA in 2014, she was an Assistant Professor at the University of Maryland, Baltimore, and a scientist at the Baltimore Veteran Affairs Medical Center with a research background in genetic and cardiovascular epidemiology. Dr. Cheng received her Ph.D. in Epidemiology from the Johns Hopkins Bloomberg School of Public Health in 2008.

About the Presentation

The Population Assessment of Tobacco and Health (PATH) Study, a national, longitudinal cohort study of tobacco use and health in the United States, is one of the first large tobacco research efforts undertaken by FDA Center for Tobacco Products (CTP) and National Institute of Health (NIH) after Congress gave FDA authority to regulate tobacco products in 2009. This presentation will share an overview and history of the PATH Study, evolution of the study design made over time in response to important changes in tobacco marketplace and regulatory environment and highlight how its designs and findings can inform tobacco regulatory science and public health.

Learning Objectives

  1. Describe the mission and vision of the Center for Tobacco Products
  2. Discuss the design and objectives of the Population Assessment of Tobacco and Health (PATH) Study
  3. Describe how scientific data generated from the PATH Study supports tobacco regulatory science and public health.

To Register

FDA employees MUST register in BOTH the following: 

Non-FDA employees must register in:

  • ZOOM REGISTRATION *Once you have registered in ZOOM, you will receive a confirmation email with the webcast URL.

After Zoom webcast registration, you will receive a link via email to access the live webinar. You must log in with the username and password created when you registered.  Please pre-register at least two days before the event to ensure you receive the access link and outlook invitation for the session. 

For technical assistance please contact: Isaac.Miller@fda.hhs.gov
 

Back to Top